Outlook Therapeutics Inc (NASDAQ:OTLK) currently has a daily average trading volume of 425.05K but it saw 933808 shares traded in last market. With a market cap of 56.92M USD, the company’s current market price of $1.75 came falling about -14.04 while comparing to the previous closing price of $2.03. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.25 and as low as $0.87.
Taking a look at 20-day trading activity of Outlook Therapeutics Inc (OTLK) gives us an average price of $1.54, while its current price level is -81.14% below from 52-week high level whereas it is 100.57% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.45 while that of 200 days or SMA-200 reads an average of $3.64. A closer look into the stock’s movement over the week reveals that its volatility is standing at 14.08% during that period while stretching the period over a month that decreases to 8.86%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 59.49 which implies that the stock is in neutral territory.
BTIG Research upgraded its recommendation for the stock as a “Buy” from “Neutral” on March 27, 2024 while assigning a price target of $50. Chardan Capital Markets issued its recommendations for the stock as it upgraded the price target for the stock is $3.
Over the week, OTLK’s stock price is moving 23.76% up while it is 25.54% when we observe its performance for the past one month. Year-to-date it is -7.67% down and over the past year, the stock is showing a downside performance of -76.98%.
Currently, Outlook Therapeutics Inc’s total number of outstanding shares is 24.91M with 36.42% of that held by the insiders while 17.14% of its common stock has been owned by the institutions. Stock’s beta reads 0.29. Its return on asset (ROA) is -241.97% on average.
